Immuno-Oncology Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of Immuno-Oncology Market

1.3 Market Segment by Type

1.3.1 China Immuno-Oncology Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027

1.3.2 China Immuno-Oncology Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

1.3.3 China Immuno-Oncology Market Size and Growth Rate of Cytokine-Based Immunotherapy from 2016 to 2027

1.3.4 China Immuno-Oncology Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027

1.3.5 China Immuno-Oncology Market Size and Growth Rate of CAR-T Cell Therapy from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China Immuno-Oncology Market Size and Growth Rate of Hospitals from 2016 to 2027

1.4.2 China Immuno-Oncology Market Size and Growth Rate of Pharmacies from 2016 to 2027

1.4.3 China Immuno-Oncology Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of Immuno-Oncology by Major Types

3.4.1 Market Size and Growth Rate of Immune Checkpoint Inhibitors

3.4.2 Market Size and Growth Rate of Monoclonal Antibodies

3.4.3 Market Size and Growth Rate of Cytokine-Based Immunotherapy

3.4.4 Market Size and Growth Rate of Cancer Vaccines

3.4.5 Market Size and Growth Rate of CAR-T Cell Therapy

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of Immuno-Oncology by Major End-Users

4.4.1 Market Size and Growth Rate of Immuno-Oncology in Hospitals

4.4.2 Market Size and Growth Rate of Immuno-Oncology in Pharmacies

4.4.3 Market Size and Growth Rate of Immuno-Oncology in Online Pharmacies

5.1 China Immuno-Oncology Production Analysis by Regions

5.2 China Immuno-Oncology Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China Immuno-Oncology Landscape Analysis by Major Types

6.2 North China Immuno-Oncology Landscape Analysis by Major End-Users

7.1 Central China Immuno-Oncology Landscape Analysis by Major Types

7.2 Central China Immuno-Oncology Landscape Analysis by Major End-Users

8.1 South China Immuno-Oncology Landscape Analysis by Major Types

8.2 South China Immuno-Oncology Landscape Analysis by Major End-Users

9.1 East China Immuno-Oncology Landscape Analysis by Major Types

9.2 East China Immuno-Oncology Landscape Analysis by Major End-Users

10.1 Northeast China Immuno-Oncology Landscape Analysis by Major Types

10.2 Northeast China Immuno-Oncology Landscape Analysis by Major End-Users

11.1 Southwest China Immuno-Oncology Landscape Analysis by Major Types

11.2 Southwest China Immuno-Oncology Landscape Analysis by Major End-Users

12.1 Northwest China Immuno-Oncology Landscape Analysis by Major Types

12.2 Northwest China Immuno-Oncology Landscape Analysis by Major End-Users

13.1 Incyte

13.2 Celgene Corporation

13.3 Novartis International AG

13.4 AstraZeneca, Plc

13.5 Johnson & Johnson

13.6 Bristol-Myers Squibb

13.7 Celldex Therapeutics

13.8 Galena Biopharma

13.9 AbbVie

13.10 Hoffmann-La Roche AG

13.11 Aduro BioTech

13.12 Prometheus Therapeutics & Diagnostics

13.13 Merck & Co

13.14 Amgen Inc

13.15 Pfizer Inc

13.16 Sanofi SA

13.17 Gilead Sciences Inc

13.18 ImmunoCellular Therapeutics

13.19 Bavarian Nordic

13.20 EMD Serono

13.21 Eli Lilly and Company

Figure Product Picture

Figure China Immuno-Oncology Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027

Figure China Immuno-Oncology Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

Figure China Immuno-Oncology Market Size and Growth Rate of Cytokine-Based Immunotherapy from 2016 to 2027

Figure China Immuno-Oncology Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027

Figure China Immuno-Oncology Market Size and Growth Rate of CAR-T Cell Therapy from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China Immuno-Oncology Market Size and Growth Rate of Hospitals from 2016 to 2027

Figure China Immuno-Oncology Market Size and Growth Rate of Pharmacies from 2016 to 2027

Figure China Immuno-Oncology Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China Immuno-Oncology Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of Immuno-Oncology Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of Immuno-Oncology

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of Immuno-Oncology by Different Types from 2016 to 2027

Table Consumption Share of Immuno-Oncology by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of Immune Checkpoint Inhibitors

Figure Market Size and Growth Rate of Monoclonal Antibodies

Figure Market Size and Growth Rate of Cytokine-Based Immunotherapy

Figure Market Size and Growth Rate of Cancer Vaccines

Figure Market Size and Growth Rate of CAR-T Cell Therapy

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of Immuno-Oncology by Different End-Users from 2016 to 2027

Table Consumption Share of Immuno-Oncology by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Hospitals

Figure Market Size and Growth Rate of Pharmacies

Figure Market Size and Growth Rate of Online Pharmacies

Table China Immuno-Oncology Production by Regions

Table China Immuno-Oncology Production Share by Regions

Figure China Immuno-Oncology Production Share by Regions in 2016

Figure China Immuno-Oncology Production Share by Regions in 2021

Figure China Immuno-Oncology Production Share by Regions in 2027

Table China Immuno-Oncology Consumption by Regions

Table China Immuno-Oncology Consumption Share by Regions

Figure China Immuno-Oncology Consumption Share by Regions in 2016

Figure China Immuno-Oncology Consumption Share by Regions in 2021

Figure China Immuno-Oncology Consumption Share by Regions in 2027

Table North China Immuno-Oncology Consumption by Types from 2016 to 2027

Table North China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure North China Immuno-Oncology Consumption Share by Types in 2016

Figure North China Immuno-Oncology Consumption Share by Types in 2021

Figure North China Immuno-Oncology Consumption Share by Types in 2027

Table North China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table North China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure North China Immuno-Oncology Consumption Share by End-Users in 2016

Figure North China Immuno-Oncology Consumption Share by End-Users in 2021

Figure North China Immuno-Oncology Consumption Share by End-Users in 2027

Table Central China Immuno-Oncology Consumption by Types from 2016 to 2027

Table Central China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure Central China Immuno-Oncology Consumption Share by Types in 2016

Figure Central China Immuno-Oncology Consumption Share by Types in 2021

Figure Central China Immuno-Oncology Consumption Share by Types in 2027

Table Central China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table Central China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure Central China Immuno-Oncology Consumption Share by End-Users in 2016

Figure Central China Immuno-Oncology Consumption Share by End-Users in 2021

Figure Central China Immuno-Oncology Consumption Share by End-Users in 2027

Table South China Immuno-Oncology Consumption by Types from 2016 to 2027

Table South China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure South China Immuno-Oncology Consumption Share by Types in 2016

Figure South China Immuno-Oncology Consumption Share by Types in 2021

Figure South China Immuno-Oncology Consumption Share by Types in 2027

Table South China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table South China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure South China Immuno-Oncology Consumption Share by End-Users in 2016

Figure South China Immuno-Oncology Consumption Share by End-Users in 2021

Figure South China Immuno-Oncology Consumption Share by End-Users in 2027

Table East China Immuno-Oncology Consumption by Types from 2016 to 2027

Table East China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure East China Immuno-Oncology Consumption Share by Types in 2016

Figure East China Immuno-Oncology Consumption Share by Types in 2021

Figure East China Immuno-Oncology Consumption Share by Types in 2027

Table East China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table East China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure East China Immuno-Oncology Consumption Share by End-Users in 2016

Figure East China Immuno-Oncology Consumption Share by End-Users in 2021

Figure East China Immuno-Oncology Consumption Share by End-Users in 2027

Table Northeast China Immuno-Oncology Consumption by Types from 2016 to 2027

Table Northeast China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure Northeast China Immuno-Oncology Consumption Share by Types in 2016

Figure Northeast China Immuno-Oncology Consumption Share by Types in 2021

Figure Northeast China Immuno-Oncology Consumption Share by Types in 2027

Table Northeast China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table Northeast China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure Northeast China Immuno-Oncology Consumption Share by End-Users in 2016

Figure Northeast China Immuno-Oncology Consumption Share by End-Users in 2021

Figure Northeast China Immuno-Oncology Consumption Share by End-Users in 2027

Table Southwest China Immuno-Oncology Consumption by Types from 2016 to 2027

Table Southwest China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure Southwest China Immuno-Oncology Consumption Share by Types in 2016

Figure Southwest China Immuno-Oncology Consumption Share by Types in 2021

Figure Southwest China Immuno-Oncology Consumption Share by Types in 2027

Table Southwest China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table Southwest China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure Southwest China Immuno-Oncology Consumption Share by End-Users in 2016

Figure Southwest China Immuno-Oncology Consumption Share by End-Users in 2021

Figure Southwest China Immuno-Oncology Consumption Share by End-Users in 2027

Table Northwest China Immuno-Oncology Consumption by Types from 2016 to 2027

Table Northwest China Immuno-Oncology Consumption Share by Types from 2016 to 2027

Figure Northwest China Immuno-Oncology Consumption Share by Types in 2016

Figure Northwest China Immuno-Oncology Consumption Share by Types in 2021

Figure Northwest China Immuno-Oncology Consumption Share by Types in 2027

Table Northwest China Immuno-Oncology Consumption by End-Users from 2016 to 2027

Table Northwest China Immuno-Oncology Consumption Share by End-Users from 2016 to 2027

Figure Northwest China Immuno-Oncology Consumption Share by End-Users in 2016

Figure Northwest China Immuno-Oncology Consumption Share by End-Users in 2021

Figure Northwest China Immuno-Oncology Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Incyte

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incyte

Figure Sales and Growth Rate Analysis of Incyte

Figure Revenue and Market Share Analysis of Incyte

Table Product and Service Introduction of Incyte

Table Company Profile and Development Status of Celgene Corporation

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

Figure Sales and Growth Rate Analysis of Celgene Corporation

Figure Revenue and Market Share Analysis of Celgene Corporation

Table Product and Service Introduction of Celgene Corporation

Table Company Profile and Development Status of Novartis International AG

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG

Figure Sales and Growth Rate Analysis of Novartis International AG

Figure Revenue and Market Share Analysis of Novartis International AG

Table Product and Service Introduction of Novartis International AG

Table Company Profile and Development Status of AstraZeneca, Plc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca, Plc

Figure Sales and Growth Rate Analysis of AstraZeneca, Plc

Figure Revenue and Market Share Analysis of AstraZeneca, Plc

Table Product and Service Introduction of AstraZeneca, Plc

Table Company Profile and Development Status of Johnson & Johnson

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

Figure Sales and Growth Rate Analysis of Johnson & Johnson

Figure Revenue and Market Share Analysis of Johnson & Johnson

Table Product and Service Introduction of Johnson & Johnson

Table Company Profile and Development Status of Bristol-Myers Squibb

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

Table Product and Service Introduction of Bristol-Myers Squibb

Table Company Profile and Development Status of Celldex Therapeutics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celldex Therapeutics

Figure Sales and Growth Rate Analysis of Celldex Therapeutics

Figure Revenue and Market Share Analysis of Celldex Therapeutics

Table Product and Service Introduction of Celldex Therapeutics

Table Company Profile and Development Status of Galena Biopharma

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galena Biopharma

Figure Sales and Growth Rate Analysis of Galena Biopharma

Figure Revenue and Market Share Analysis of Galena Biopharma

Table Product and Service Introduction of Galena Biopharma

Table Company Profile and Development Status of AbbVie

Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

Figure Sales and Growth Rate Analysis of AbbVie

Figure Revenue and Market Share Analysis of AbbVie

Table Product and Service Introduction of AbbVie

Table Company Profile and Development Status of Hoffmann-La Roche AG

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche AG

Figure Sales and Growth Rate Analysis of Hoffmann-La Roche AG

Figure Revenue and Market Share Analysis of Hoffmann-La Roche AG

Table Product and Service Introduction of Hoffmann-La Roche AG

Table Company Profile and Development Status of Aduro BioTech

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aduro BioTech

Figure Sales and Growth Rate Analysis of Aduro BioTech

Figure Revenue and Market Share Analysis of Aduro BioTech

Table Product and Service Introduction of Aduro BioTech

Table Company Profile and Development Status of Prometheus Therapeutics & Diagnostics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prometheus Therapeutics & Diagnostics

Figure Sales and Growth Rate Analysis of Prometheus Therapeutics & Diagnostics

Figure Revenue and Market Share Analysis of Prometheus Therapeutics & Diagnostics

Table Product and Service Introduction of Prometheus Therapeutics & Diagnostics

Table Company Profile and Development Status of Merck & Co

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

Figure Sales and Growth Rate Analysis of Merck & Co

Figure Revenue and Market Share Analysis of Merck & Co

Table Product and Service Introduction of Merck & Co

Table Company Profile and Development Status of Amgen Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

Figure Sales and Growth Rate Analysis of Amgen Inc

Figure Revenue and Market Share Analysis of Amgen Inc

Table Product and Service Introduction of Amgen Inc

Table Company Profile and Development Status of Pfizer Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

Figure Sales and Growth Rate Analysis of Pfizer Inc

Figure Revenue and Market Share Analysis of Pfizer Inc

Table Product and Service Introduction of Pfizer Inc

Table Company Profile and Development Status of Sanofi SA

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA

Figure Sales and Growth Rate Analysis of Sanofi SA

Figure Revenue and Market Share Analysis of Sanofi SA

Table Product and Service Introduction of Sanofi SA

Table Company Profile and Development Status of Gilead Sciences Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

Figure Revenue and Market Share Analysis of Gilead Sciences Inc

Table Product and Service Introduction of Gilead Sciences Inc

Table Company Profile and Development Status of ImmunoCellular Therapeutics

Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImmunoCellular Therapeutics

Figure Sales and Growth Rate Analysis of ImmunoCellular Therapeutics

Figure Revenue and Market Share Analysis of ImmunoCellular Therapeutics

Table Product and Service Introduction of ImmunoCellular Therapeutics

Table Company Profile and Development Status of Bavarian Nordic

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic

Figure Sales and Growth Rate Analysis of Bavarian Nordic

Figure Revenue and Market Share Analysis of Bavarian Nordic

Table Product and Service Introduction of Bavarian Nordic

Table Company Profile and Development Status of EMD Serono

Table Sales, Revenue, Sales Price and Gross Margin Analysis of EMD Serono

Figure Sales and Growth Rate Analysis of EMD Serono

Figure Revenue and Market Share Analysis of EMD Serono

Table Product and Service Introduction of EMD Serono

Table Company Profile and Development Status of Eli Lilly and Company

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

Figure Sales and Growth Rate Analysis of Eli Lilly and Company

Figure Revenue and Market Share Analysis of Eli Lilly and Company

Table Product and Service Introduction of Eli Lilly and Company